15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Aemetis Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $22.00 to $22.00, so the covering firms are broadly aligned. The average target of $22.00 sits 1381% above the current $1.49. The rating mix has stayed broadly stable, with Buy-side ratings easing from 2 to 1 over recent months. On the fundamentals, the Street sees revenue growth near 21% this year and 77% next, consensus EPS building from about $-0.19 next quarter toward $-0.59 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Aemetis Inc.
As of Jul, 1 of 1 firms rate AMTX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AMTX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.19
Range $-0.22 – $-0.14 · 3 analysts · -50% YoY
Next period, 3 analysts expect Aemetis Inc to earn $-0.19 a share (range $-0.22 – $-0.14), versus $-0.37 a year earlier. Full-year consensus is $-0.90, growing to $-0.59 the year after.
REVENUE · NEXT QUARTER
$73.8M
Range $61.2M – $81.6M · 3 analysts · +3% YoY
Revenue is expected to reach $73.8M (range $61.2M – $81.6M), +3.0% year-over-year. Full-year consensus is $279.4M, rising to $398.1M next year.
Top analysts covering Aemetis Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AMTX.
#1
Amit Dayal
HC Wainwright & Co. · Rank #332
Buy
$28.00+1785.5% to target
Overall win rate
25%
+ Follow
#2
Edward Woo
Ascendiant Capital · Rank #358
Buy
$22.00+1381.5% to target
Overall win rate
26%
+ Follow
#3
Manav Gupta
UBS
Buy
$3.00+102.0% to target
Coverage
—
+ Follow
#4
DW
Derrick Whitfield
Texas Capital Securities
Hold
$2.50+68.4% to target
Coverage
—
+ Follow
#5
JL
Jordan Levy
Truist Securities
Hold
$3.50+135.7% to target
Coverage
—
+ Follow
AMTX stock forecast FAQ
What is AMTX's average 12-month price target?+
The 1 analysts with a live target average $22.00 for Aemetis Inc over the next 12 months, ranging from a $22.00 high to a $22.00 low.
Is AMTX stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover AMTX?+
1 analysts have an active rating on Aemetis Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering AMTX?+
Among analysts who currently cover AMTX, Amit Dayal of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #332). Their current call is Buy with a $28.00 target.
What is Aemetis Inc's projected EPS for next quarter?+
The consensus estimate is $-0.19 per share (range $-0.22 – $-0.14) across 3 analysts. Full-year EPS is projected at $-0.90, rising to $-0.59 the following year.
How much revenue is Aemetis Inc expected to report next quarter?+
Consensus revenue is $73.8M (range $61.2M – $81.6M). Full-year revenue is projected at $279.4M, growing to $398.1M next year.
Have analysts been upgrading or downgrading AMTX lately?+
As of Jul, 1 of 1 firms rate AMTX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AMTX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
